Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01644903 · ClinicalTrials.gov registry record
Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
A clinical trial of Hepatitis C and Chronic Kidney Disease, sponsored by Northwestern University.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT01644903: Recruiting study of Hepatitis C and Chronic Kidney Disease, sponsored by Northwestern University.
NCT01644903 is a study of Hepatitis C and Chronic Kidney Disease that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 1,000 participants, below the 1,881-participant average among 106 other Hepatitis C trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01644903, a study of Hepatitis C and Chronic Kidney Disease, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to test blood, urine and tissue samples to see if this can help decide if CKD (Chronic Kidney Disease), AR (Acute Rejection) and HCV (Hepatitis C Virus) can be identified in its early stages. CKD damage to the kidneys, AR and HCV all lower the body's ability to function properly. Early detection of these conditions could assist with successful treatment and possibly lead to less repeat organ transplants.
Primary Outcome
To validate specific proteogenomic biomarker panels for CKD and AR (and HCV) in a prospective serial blood and urine monitoring study of liver transplant recipients
Conditions Studied
Study Locations (1)
Illinois
- Northwestern Memorial Hospital - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2010-04 |
| Est. Completion | 2028-12 |
What NCT01644903 shows while recruiting
NCT01644903 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 1,881-participant average among 106 other Hepatitis C trials with a reported enrollment target (47% lower).
The record links to 4 conditions, with Hepatitis C appearing as the primary indexed condition, and to 0 interventions.
NCT01644903 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT01644903 about?
NCT01644903 is a clinical study titled "Proteogenomic Monitoring and Assessment of Liver Transplant Recipients". This study is being done to test blood, urine and tissue samples to see if this can help decide if CKD (Chronic Kidney Disease), AR (Acute Rejection) and HCV (Hepatitis C Virus) can be identified in its early stages. CKD damage to the kidneys, AR and HCV all lower the body's ability to function prop...
What is the current status of trial NCT01644903?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2010-04. Estimated completion is 2028-12.
What conditions does trial NCT01644903 study?
This clinical trial studies the following conditions: Hepatitis C, Chronic Kidney Disease, Liver Transplant, Acute Rejection.
Who is sponsoring clinical trial NCT01644903?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01644903 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis C
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01644903's enrollment target sits among peer trials
1,000 6th of 106 higher than 100 of 106 other Hepatitis C trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hepatitis C trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
DBS TaT in Peer-assisted Telemedicine for Hepatitis C
RECRUITING · NA
-
Evaluation of Patients With Liver Disease
RECRUITING
-
The HOPE Study: Characterizing Patients With Hepatitis B and C
RECRUITING
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
RECRUITING · NA
-
The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia